
ãã£ãªãã³ã¯2028幎ãŸã§ã«äººå£åŽ©å£ã«çŽé¢ããå¯èœæ§ããã
å èšäºã¯ãã¡ããã/Click here to read the original article.
å é±ãã£ãªãã³çµ±èšå±ãçºè¡šããããŒã¿ã«ãããšã2021幎ã¯2020å¹Žãšæ¯èŒããŠãçå åºçæ°ã10.7ïŒ æžå°ããã ãŸãã2012å¹Žãšæ¯èŒãããšã2021幎ã®ç»é²åºçæ°ã¯23.8ïŒ æžå°ããŠããã ãã®æžå°ã«æ»äº¡ã®å¢å ãéãªãã°ããã£ãªãã³ã¯2028幎ãŸã§ã«äººå£å¢å çããã€ãã¹ã«ãªããšããããã£ãªãã³ã¯çé±ã®ã«ããªã¢ãïŒ
ãã£ãªãã³çµ±èšå±ã®äººå£ãã©ãããã«ããããã«ã人å£ã®å€§éšåã¯çæ®å¹Žéœ¢ã«ããã女æ§äººå£ã®åå以äžãçæ®å¹Žéœ¢ã§ããããããã£ãŠããã£ãªãã³ã®åºççãããã»ã©æ¥æ¿ã«äœäžããããšã¯ãªããšæãããŸãã ããã§ãSuper Sallyã¯ããŒã¿ãèŠãªããã2021幎ã®åºççäœäžã®åå ãšããŠèããããããšãæ¢ã£ãŠã¿ãŸããã
ãã®ããŒã¿ã«ã¯æ³šæç¹ããããŸãã åºçç»é²ãå®äºãããŸã§ã«4ã¶æãããã2022幎3æ31æ¥æç¹ã®ããŒã¿ãªã®ã§ã次ã®ããŒã¿çºè¡šã§ã¯10.7ïŒ ã®æžå°ãçž®å°ããå¯èœæ§ããããŸãã

BARMMãé€ããã£ãªãã³ã®å šå°åã§ã2021幎äžã®ç»é²çå æ°ã¯2020å¹Žã«æ¯ã¹ãŠæžå°ããã åºçæ°ã®æžå°ã¯ãRegion IXã®4.2ïŒ ããNCRã®19.1ïŒ ã«åãã ã äŸå€ã§ããBARMMã¯6.6ïŒ ã®å¢å ãšãªã£ãã
ã³ãã察çãšå®¶æèšç»ã®å¹æ
åºç£ã¯åèãã9ã10ã«æåŸã«è¡ããããããå幎ã®åºæ¥äºãåºçæ°ã«åœ±é¿ããã 2020幎ã®éãè¡ãããçµå©ã®æ°ã¯éå»50幎éã§æäœã ã£ããšã¹ãŒããŒãµãªãŒã¯æžããŠãããããã¯ãééãèªå® åŸ æ©åœä»€ãªã©ã®ã³ãã察çãåå ã§ããå¯èœæ§ãããã çµå©ãå°ãªããã°ãç¿å¹Žã®åºçæ°ã¯å°ãªããªãã ããããã¹ãŒããŒãµãªãŒãææããããã«ã忰以äžïŒ57.1ïŒ ïŒãæªå©ã®æ¯èŠªããçãŸããŠããã®ã§ããããçµå©ããŠãããªããŠããåå«ç¹æ ã«ã¯åœ±é¿ããªãã®ã ãã
åºçæ°ã®æžå°ã®ããäžã€ã®èŠå ã¯ããã£ãªãã³éçºèšç»ïŒPDPïŒ2017-2022ã®äžç°ãšããŠã2017幎ãããã£ãªãã³ã§å®æœãããŠããç©æ¥µçãªå®¶æèšç»ãããããŸãããPDPã¯ãåœæ°ãå¥åº·ã§æè²ãåããŠãããè±ãã§ä¿¡é Œæ§ã®é«ãäžæµéçŽã®ãã£ãªãã³ç€ŸäŒãæ§æ³ãã25幎èšç»ãAmBisyon Natin 2040ãã軞ã«ãããŸããŸãªç®æšãæ²ããããŠããŸãã ãã®èšç»ã«ã¯ãåœé£ïŒä»¥äžãåœé£ïŒã®ã¢ãžã§ã³ã2030ã®æç¶å¯èœãªéçºç®æšïŒä»¥äžãSDGsïŒãéæããããã®æŠç¥ãæ¿çãå«ãŸããŠããŸãã
仿åããåœå®¶çµæžéçºåºã®ãžã§ã»ãã»Jã»ã«ããŒã次å®ã¯ãPDPãšSDGsã®å¯æ¥ãªé¢ä¿ã確èªãããã®æ žå¿ã¯ãSDGsãšPDPãå ±éã®éå¿ã«ãã£ãŠçµã°ããŠããããšã ãšè¿°ã¹ãŸããããPDPã®ç« ã¯ãã¹ãŠã§ã¯ãªãã«ãããã»ãšãã©ãSDGsãšäžèŽããŠããŸãããšåœŒã¯èšããŸããã
ãã£ãªãã³æ¿åºã¯ãå®¶æèšç»ããããã®ç®æšãéæããããã®æ¥µããŠéèŠãªä»å ¥ãšããŠäœçœ®ã¥ããŠããŸãã
ã³ããæ³šå°ã®å¹æ
2021幎3æ1æ¥ããã£ãªãã³ã§ã³ããæ³šå°ãã£ã³ããŒã³ãæ£åŒã«éå§ãããŸããã ååå ¥è·åã¯60äžæ¬ã®ã¿ã§ãã£ããããæ³šå°ã®æäžã¯ããã©éŠéœåãšå»çåŸäºè ã«éå®ãããŸããã 2021幎5æã«äžè¬äœæ°ã®æ³šå°ãéå§ããã2021幎10æäžæ¬ããæªæå¹Žè ãžã®æ¥çš®ãéå§ãããŸããã
åŠå©Šãžã®ã¯ã¯ãã³æ¥çš®ã¯ãä¿å¥çããã³ãã£ãªãã³ç£ç§å©Šäººç§åŠäŒã«ãã£ãŠåŒ·ã奚å±ãããŸããããå€ãã®åŠå©ŠãšåŠåš ãèšç»ããŠãã女æ§ãã¯ã¯ãã³æ¥çš®ãåãã ããšã¹ãŒããŒãµãªãŒã¯æžããŠããŸãã ãåœéçãªããŒã¿ããŸããŸã瀺åããŠããããã«ãåºççã«æªåœ±é¿ããããšããã°ããã£ãªãã³ã¯2022幎以éãåºçæ°ãããã«ããªãæžå°ããããšã«ãªããããããŸãããã
2022幎ã®äºåããŒã¿ã§ã¯ããããªãæžå°ã確èªãããŠããããã§ãã ã2022幎ã®åºççã®äºåããŒã¿ã¯ãåºçæ°ã2021幎ã®ã¬ãã«ãäžåãã4æïŒäžè¬å±éåŸ10ã¶æïŒããå§ãŸãããã®åŸã¯æšªã°ãã«ãªãããã§ãéåžžã«æ°ã«ãªãç¶ç¶çãªäœäžã瀺ããŠããããã§ãã ã¹ãŒããŒãµãªãŒããã¯ããæžããŠããŸãã

ãWHOãå ¬è¡è¡çé¢ä¿è ã¯ãã»ãšãã©ã®äººã«Covid-19ã®æ¥çš®ãåŒ·ãæšå¥šãç¶ããŠããŸãããåŠåš å¯èœãªå¹Žéœ¢ãç·å¥³ã®ãã¹ãŠã®äººãžã®ãããªãæ¥çš®ãã¢ã©ããªã¢ã ããããæ±ããå°éå®¶ã®å£°ãé«ãŸã£ãŠããŸãããšãã¹ãŒããŒãµãªãŒã¯èŠåããŠããŸããããŸãã害ãåãŒããšããå€ãã®éžè©±çãªå ±åããããŸãããšã¹ãŒããŒãµãªãŒã¯èŠåããŠããŸãã ãå ¬è¡è¡çæ åœè ã¯èª¿æ»ããå¿ èŠããããå»åž«ã¯éåžžã«é«ãçãææ°ãæã¡ãæå®³äºè±¡ãçºçããå Žåã¯å ±åããããã«ããªããã°ãªããªãã ãšã
人å£åŽ©å£
人å£åŽ©å£ãšã¯ã人å£ãæžå°ããããšã§ãã éçåãéå°äººå£ãšåŒã°ããããšãããã åœé£ã®ãäžç人å£å±æ2022ãïŒä»¥äžãåœé£ããŒã¿ïŒã«ãããšãäžçã®äººå£å¢å ã¯ãäž»ã«äžçã®åèšç¹æ®åºççã1963幎ã®5.3ãã2021幎ã®2.32ãžã𿥿¿ã«äœäžããããšã«èµ·å ããŠããã
åèšç¹æ®åºççãšã¯ã女æ§äžäººãåºç£å¯èœãªæéã«ç£ãåäŸã®æ°ã§ãããç§»æ°ãç¡èŠããŠäººå£ãç¶æããããã«ã¯ãäžäººã®å¥³æ§ã«ã€ã2.1人以äžã®åºççãå¿ èŠã§ããã
åœé£ã®ããŒã¿ã«ãããšããã£ãªãã³ã®åºççã¯äžçã¬ãã«ãããäœäžããŠããã1963幎ã®6.95ãã2021幎ã«ã¯2.75ã«äœäžããŠããã 2012幎ã®åºççã¯ã女æ§äžäººåœãã3.13人ã§ãã£ãã 2012幎ãã2021幎ãŸã§ã®10幎éã®åºççã®äœäžã¯12ïŒ ïŒïŒ3.13-2.17ïŒ/3.13ïŒÃ100ïŒã§ããã
ããã²ãšã€ã®ææšã¯ã人å£1,000人ãããã®çå æ°ã§ããç²åºççã§ããããã£ãªãã³çµ±èšå±ã¯ã2021幎ã®ç²åºççã¯1,000人ããã12人ã§ãããšææããŠãããéã«ãåœé£ã®ããŒã¿ã«ãããšãç²æ»äº¡çã¯1,000人ããã7.3人ã§ãã£ãã1,000人ããã2.7人ã®èªç¶å¢å çã
2012幎以éã®ç²æ»äº¡çã¯1,000人ããã5.6ïœ5.8ã®éã§æšç§»ããŠãããããã³ãããã¯ãã®å¹Žã§ãã2020幎ãå«ãã1990幎代åã°ããäžå®ã®å²åã§æšç§»ããŠããã ãããã£ãŠ2021幎ã«ã¯ãç²æ»äº¡çã¯ããã28ïŒ ïŒïŒ7.3ïœ5.7ïŒ/7.3ïŒÃ100ïŒå¢å ããããšã«ãªãã
ã€ãŸããå°ååãé²ã¿ã2021幎ã®ç»é²åºçæ°ã10ïŒ æžå°ããäžæ¹ã§ã2021å¹Žã®æ»äº¡çã¯28ïŒ å¢å ããããšã«ãªãã
åºççãšæ»äº¡çã®çŸåšã®åŸåãç¶ãã°ããã£ãªãã³ã¯5幎以å ã«ããããã2028幎ãŸã§ã«äººå£ããã€ãã¹æé·ã«ãªããšSuper Sallyã¯æžããŠããŸãããæ»ãå éããåºçãæžå°ãããããªããšãããã°ããã®äžæå¿«ãªãã€ã«ã¹ããŒã³ã¯ãã£ãšæ©ãããããããã£ãšãã£ãšæ©ãéæããããããããªãã

ã¹ãŒããŒãµãªãŒããã®èšäºã¯ãã¡ãã§èªããŸãã
人å£åŽ©å£ã¯ããã£ãªãã³ã ãã®åé¡ã§ã¯ãããŸããã 2020幎ãã¯ã·ã³ãã³å€§åŠã®Institute for Health Metrics and Evaluationã®ç ç©¶è ã¯ã2100幎ãŸã§ã«äžçã®åºççã1.7ãäžåããšäºæž¬ããç ç©¶ãThe Lancetã«çºè¡šãããè±åœãå«ãåœã ã¯ãç§»æ°ãå©çšããŠäººå£ãå¢ãããåºççã®äœäžãè£ã£ãŠãããšBBCã¯å ±ããŠããã BBCã®èšäºã§ã¯ãã»ãŒãã¹ãŠã®åœã®äººå£ãæžå°ãããšãç§»æ°ã¯çãã§ã¯ãªããªãããšææããŠããã
æ¿åºãå ¬çæ©é¢ãäŒæ¥ã¡ãã£ã¢ãå€§äŒæ¥ãããªã人å£ãæäœããäžåŠãåŒãèµ·ããããšãç¥ãããŠããã³ãããã¯ã¯ãã³ããæ³šå°ãããã匷å¶ããŠããã®ãããšããçåãæããããŠããã®ã§ããã ããäžã€ã®äžåãªäºå®ã¯ãã¯ã·ã³ãã³å€§åŠã®ç ç©¶ããã«ïŒã¡ãªã³ãã»ã²ã€ã財å£ããè³éæäŸãåããŠããããšã§ããã ããã¯ãã§ã©ãŒã®åå«ã§ãããã«ã»ã²ã€ãã¯ãåœé£ã®ã¢ãžã§ã³ã21ãšã¢ãžã§ã³ã2030ã®æ çµã¿ã®äžã§äººå£æå¶ãšéçåã®é¡ãšãªãããšã人çã®ç®æšãšãããã£ãäžã€ã®ç®æšã«çªãé²ãã§ããã®ã§ããã
ãããŒã¿ã§èŠãç§ãã¡ã®äžçãã§ã¯ãåœé£ã®äºæž¬ãçšããŠãåœãå°åãäžçããšã®äººå£å¢å çã®ã°ã©ãã衚瀺ããŠããŸãã åœé£ã¯2092幎ãŸã§ã«ãã£ãªãã³ã®äººå£ãç§»äœãå«ããŠãã€ãã¹æé·ã«ãªããšäºæž¬ããŠãããããã¯ãäžçå šäœã§äºæž¬ãããŠãããŒãæé·ä»¥äžããã7幎é ãã2086幎ãŸã§ã«äžçã®äººå£ããã€ãã¹æé·ã«ãªããšäºæž¬ãããŠããã


åœé£ã®é·æäºæž¬ã§ã¯ããã£ãªãã³ã®äººå£åŽ©å£ã¯äžçå šäœã®åŸã«èµ·ãããšãããŠããããšãèãããšã2028幎ãŸã§ã«äººå£ããã€ãã¹æé·ãããšãããã£ãªãã³ã®çŸåšã®èŠå¢ã¯ãäžçã®ä»ã®åœã ã«ãšã£ãŠçé±ã®ã«ããªã¢ãªã®ã ãããã